CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
rAAV2-ND4drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01267422
NCT01267422N/ACompleted
CompareCT.gov

Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy

Bin Li·interventional·Posted Dec 28, 2010·Updated Jan 31, 2018

In Brief

A clinical study evaluating rAAV2-ND4 for Leber Hereditary Optic Neuropathy. Completed, enrolled 9 participants across 1 site.

Detailed Summary

This study is meant to assess the safety and efficacy of rAAV2-ND4 treatment of Leber hereditary optic neuropathy with 11778 LHON mutation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLeber Hereditary Optic Neuropathy
CountriesChina
CollaboratorsHuazhong University of Science and Technology

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 28, 2010
Enrollment StartApr 1, 2011
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 15.5 years ago

Interventions

rAAV2-ND4drug

injection